Also trades as: 1466.HK (HKSE) · $vol 0M
MNNGF OTC
Baijin Life Science Holdings Limited
1W: +0.0%
1M: +50.0%
3M: +100.0%
YTD: +150.0%
1Y: +87.5%
3Y: +150.0%
5Y: +1150.0%
$0.15
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$264M
-8.9% ▼
5Y CAGR: +23.6%
Total Liabilities
$72M
-46.3% ▼
5Y CAGR: +9.5%
Shareholders Equity
$185M
+32.9% ▲
5Y CAGR: +32.1%
Cash & Investments
$43M
-9.8% ▼
5Y CAGR: +12.0%
Total Debt
$28M
-71.6% ▼
5Y CAGR: -2.1%
Net Debt
-$15M
-128.2% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $24M | $41M | $38M | $48M | $43M |
| Short-Term Investments | $0 | $587K | $709K | $0 | $0 |
| Cash & ST Investments | $24M | $42M | $39M | $48M | $43M |
| Net Receivables | $5M | $7M | $39M | $109M | $60M |
| Inventory | $24M | $45M | $44M | $71M | $58M |
| Other Current Assets | $21M | $420K | $14M | $0 | $928K |
| Total Current Assets | $80M | $99M | $121M | $227M | $192M |
| Property, Plant & Equip. | $3M | $979K | $9M | $17M | $31M |
| Goodwill & Intangibles | $0 | $0 | $56M | $34M | $20M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $1M |
| Other Non-Current Assets | $0 | $0 | $11M | $11M | $19M |
| Total Non-Current Assets | $3M | $979K | $75M | $63M | $72M |
| Total Assets | $82M | $100M | $197M | $290M | $264M |
| — Liabilities — | |||||
| Accounts Payable | $5M | $9M | $8M | $8M | $10M |
| Short-Term Debt | $30M | $2M | $9M | $13M | $23M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $3M |
| Other Current Liabilities | $8M | $10M | $18M | $10M | $19M |
| Total Current Liabilities | $45M | $22M | $41M | $50M | $65M |
| Long-Term Debt | $0 | $0 | $40M | $75M | $0 |
| Other Non-Current Liab. | $0 | $0 | $2M | $773K | $908K |
| Total Non-Current Liabilities | $779K | $0 | $43M | $85M | $8M |
| Total Liabilities | $46M | $22M | $84M | $134M | $72M |
| — Equity — | |||||
| Common Stock | $6M | $13M | $14M | $15M | $19M |
| Retained Earnings | -$569M | -$561M | -$560M | -$560M | $0 |
| Accumulated OCI | $6M | $7M | $0 | $0 | $0 |
| Total Stockholders Equity | $36M | $78M | $96M | $139M | $185M |
| Total Liabilities & Equity | $82M | $100M | $197M | $290M | $264M |
| — Key Metrics — | |||||
| Total Debt | $32M | $3M | $51M | $100M | $28M |
| Net Debt | $8M | -$39M | $13M | $52M | -$15M |
| Total Investments | $0 | $587K | $709K | $0 | $1M |